Paolo Verderio

24PUBLICATIONS
156CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHealth informatics and information systemsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 16, 2026
A Chronobiological Prognostic Model for Resected Stage I Non-Small-Cell Lung Cancer.

|Jul 30, 2026
Feasibility and Activity of Concurrent Neoadjuvant Chemotherapy and Radiotherapy in Patients with High-risk Soft-Tissue Sarcoma.

|Apr 14, 2026
Single Cancer Center Experience on Patient Blood Management Eligibility in Oncological Surgery.

Camilla L'Acqua, Roberto Lillini, Rosamaria Limuti

|Sep 26, 2025
Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian Cancer.

Chiara Maura Ciniselli, Elena Conca, Michele Bartoletti

|Mar 09, 2025
Reliability of core needle biopsy for HER2-low early-stage breast cancer.

C M Ciniselli, P Verderio, V Duroni

|Feb 13, 2025
The G-quadruplex experimental drug QN-302 impairs liposarcoma cell growth by inhibiting MDM2 expression and restoring p53 levels.

Beatrice Tosoni, Eisa Naghshineh, Irene Zanin

Pageof 4

Frequent Collaborators

10 joint publications

Chiara Maura Ciniselli

5 joint publications

Mara Lecchi

4 joint publications

Alessandro Gronchi

3 joint publications

Paolo Giovanni Casali